Congress
MapWatchScheduleDaily RecordMembersCommitteesLegislationNominations
Money & Oversight
MoneyOffice SpendingSubpoenasHouse EthicsForeign InfluenceSpecial Rules
Executive & Law
AgenciesRegulationsUS Code

Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Search⌘K
Congress
MapWatchScheduleDaily RecordMembersCommitteesLegislationNominations
Money & Oversight
MoneyOffice SpendingSubpoenasHouse EthicsForeign InfluenceSpecial Rules
Executive & Law
AgenciesRegulationsUS Code

Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

13,034
rulemaking dockets
4,738
open for public comment
You can weigh in on these right now
Source: Regulations.gov.

Showing 30 of 13,034 dockets

Nonrulemaking
FDA

FDA-2001-P-0057

ANDA Suitability Petition for Ganciclovir Sodium Injection

1 docNo comments
Nonrulemaking
FDA

FDA-2001-N-0566

New Animal Drugs for Investigational; Agency Information Collection Activities

4 docsNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2001-D-0137

Evaluation of the Effects of Orally Inhaled & Intranasal

12 docsNo comments
Comments due Feb 5, 2002
Nonrulemaking
FDA

FDA-2026-H-1875

DAB Civil Money Penalty; NB & MM Company Inc. d/b/a Cowboy’s 13; CLOSED 4/3/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-1572

DAB Civil Money Penalty; One Love 325 Realty LLC d/b/a Marathon; CLOSED 4/3/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2025-H-6573

DAB Civil Money Penalty; Morrison LLC d/b/a Country Corner; CLOSED 4/3/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2001-P-0238

Determine Status of Oxycontin Extended-Release Tabs. 160 mg

5 docsNo comments
Nonrulemaking
NRC
Open for Comments

NRC-2025-0413

Nuclear Regulatory Commission Seeks Public Comment on NRCareers Job Portal Data Collection

1 doc1 comment
Comments due May 27, 2026
Nonrulemaking
FDA

FDA-2001-N-0567

Substances Prohibited from Use in Animal Food/Feed Ruminant

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-2520

DAB Civil Money Penalty; 7-Eleven Inc. and Daytona Investments VIII LLC d/b/a 7-Eleven 25181B / Texaco; CLOSED 04/03/2026

1 docNo comments
Nonrulemaking
FSIS
Open for Comments

FSIS-2026-0067

USDA Seeks Renewal of Paperwork for New Poultry Inspection System; Public Comments Open

1 docNo comments
Comments due Jun 3, 2026
Nonrulemaking
ED
Open for Comments

ED-2026-SCC-0595

Education Department Seeks Comments on New State Workforce Program Data Collection

3 docs3 comments
Comments due May 20, 2026
Nonrulemaking
FDA

FDA-2026-H-2576

DAB Civil Money Penalty; Gadhimai LLC, d/b/a Family Discount / Family Food Mart; CLOSED 04/03/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2014-E-2328

FDA Sets Regulatory Review Period for Iron Drug INJECTAFER, Enabling Patent Extension Request

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-1672

FDA Sets Regulatory Review Period for ENCELTO, Allowing Patent-Extension Request

7 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
ED
Open for Comments

ED-2026-SCC-1090

Education Dept. Seeks Comments to Extend Indian Education Grant Application System

3 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0158

FDA Sets Regulatory Review Period for HYMPAVZI, Opening Patent-Extension Comment Window

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2001-N-0105

Third-Party Submissions Review/Quality System Inspections

3 docsNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-3626

FDA Sets Regulatory Review Period for ENFLONSIA, Enabling Patent-Extension Filing

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
ED
Open for Comments

ED-2026-SCC-1057

Education Department Seeks to Renew Annual Data Report on Children in State-Run Institutions

3 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-3074

FDA Sets Regulatory Review Period for EMRELIS, Allowing Patent-Extension Applications

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2001-N-0106

Safety & Effectiveness of New Drug & Biological Products in Pediatric Patients

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-3073

FDA Sets Regulatory Review Period for EMRELIS, Allowing Patent-Extension Applications

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2001-N-0173

Rapid Response Surveys; Agency Information Collection Activities

3 docsNo comments
Nonrulemaking
FDA

FDA-2001-N-0227

Format & Content Requirements for OTC Drug Product Labeling

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0872

FDA Sets Regulatory Review Period for VYLOY, Clearing Way for Patent Extension Request

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0871

FDA Sets Regulatory Review Period for VYLOY, Clearing Way for Patent Extension Request

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA

FDA-2025-H-5930

DAB Civil Money Penalty; Broadway Grocery Corp d/b/a Broadway Grocery Corp; CLOSED 4/3/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0870

FDA Sets Regulatory Review Period for VYLOY, Clearing Way for Patent Extension Request

6 docsNo comments
Comments due Jun 3, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-E-0869

FDA Sets Regulatory Review Period for VYLOY, Clearing Way for Patent Extension Request

6 docsNo comments
Comments due Jun 3, 2026
  • Previous
  • Page 329 of 435
  • Next